Cellularevolution Limited (11732114): administration
- Status
- Administration ended
- Administration began
- 2025-08-12
- Administrators' firm
- CBR Advisory
- Incorporated
- 2018-12-18
- Location
- Leeds
- Industry
- 72110 Research and experimental development on biotechnology
Why it went into administration
- Funding withdrawn / unable to refinance
From the administrators' statement
2.1. The Company was incorporated on 18 December 2018 and commenced trading as CellRev. On incorporation, Marina Miotto was the sole Director. The Company’s activities included research and development in respect of Biotechnology.
2.2 Ms Miotto acted as the sole director from incorporation until Che Connon and Leo Groenewegen were appointed in 2019. In 2022, Chris Green and Alex Buchan were appointed as directors and Mr Groenewegen resigned. Helmsway Limited were appointed as a corporate director in 2023 and Poltilove Enterprises LLC in 2024. By the time the Company entered into Administration, the Company had a total of six directors, two of which were corporate directors.
2.3. Founded as a Newcastle University spin-out, the Company was a biotech firm specialising in enzyme technology for cultivated meat, regenerative medicine and vaccine sectors.
Administrators' statement of proposals (2025-10-09) · Companies House register